ConductScience.org, home

Paper32130337

Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology.

Baddini-Martinez J and 21 others. J Bras Pneumol, 2020. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology. Papers, record 32130337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32130337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology.
PubMed
Journal
J Bras Pneumol
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.56
iCite
Revised in PubMed
2024-08-18
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baddini-Martinez JJoséhttps://orcid.org/0000-0001-8160-5084
2Ferreira JJulianahttps://orcid.org/0000-0001-6548-1384
3Tanni SSuzanahttps://orcid.org/0000-0002-2587-2759
4Alves LRLuis Renatohttps://orcid.org/0000-0001-5528-0597
5Cabral Junior BFBenedito Franciscohttps://orcid.org/0000-0001-5657-7878
6Carvalho CRRCarlos Roberto Ribeirohttps://orcid.org/0000-0002-1618-8509
7Cezare TJTalita Jaconhttps://orcid.org/0000-0002-4183-8542
8Costa CHDClaudia Henrique dahttps://orcid.org/0000-0001-6785-0753
9Gazzana MBMarcelo Bassohttps://orcid.org/0000-0003-0086-1890
10Jezler SSérgiohttps://orcid.org/0000-0002-5861-3681
11Kairalla RARonaldo Adibhttps://orcid.org/0000-0001-7194-0479
12Kawano-Dourado LLeticiahttps://orcid.org/0000-0003-0784-1331
13Lima MSMariana Silvahttps://orcid.org/0000-0002-5438-3428
14Mancuzo EElianehttps://orcid.org/0000-0003-3891-875X
15Moreira MACMaria Auxiliadora Carmohttps://orcid.org/0000-0002-6639-0633
16Rodrigues MPMarcelo Palmeirahttps://orcid.org/0000-0002-9895-646X
17Rodrigues SCSSilvia Carla Sousahttps://orcid.org/0000-0002-4909-9617
18Rubin ASAdalberto Sperbhttps://orcid.org/0000-0002-4591-1444
19Rufino RLRogério Lopeshttps://orcid.org/0000-0002-5071-6045
20Steidle LJMLeila John Marqueshttps://orcid.org/0000-0002-5435-8193

Source PubMed

See all 22 authorsDownload CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Idiopathic Pulmonary FibrosisMajor topic
Practice Guidelines as TopicMajor topic
Acetylcysteine
Aged
Anti-Inflammatory Agents
Brazil
Humans
Indoles
Male
Pyridones

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in32402013Pharmacological treatment of idiopathic pulmonary fibrosis: time to step out of the comfort zone?https://conductscience.org/library/papers/32402013

Source PubMed

Download CSV of comments and corrections

References92

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130578394Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis.Eur Respir J2019https://conductscience.org/library/papers/30578394PubMed
231365380Pulmonary hypertension due to interstitial lung disease.Curr Opin Pulm Med2019https://conductscience.org/library/papers/31365380PubMed
329341047German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017.Pneumologie2018https://conductscience.org/library/papers/29341047PubMed
428787186A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis.Am J Respir Crit Care Med2018https://conductscience.org/library/papers/28787186PubMed
531053121Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry.BMC Pulm Med2019https://conductscience.org/library/papers/31053121PubMed
625806913Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib.N Engl J Med2015https://conductscience.org/library/papers/25806913PubMed
726400368Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis.Respir Res2015https://conductscience.org/library/papers/26400368PubMed
830610155Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis.Thorax2019https://conductscience.org/library/papers/30610155PubMed
923312392GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations.J Clin Epidemiol2013https://conductscience.org/library/papers/23312392PubMed
1022782597Highlights of the Brazilian Thoracic Association guidelines for interstitial lung diseases.J Bras Pneumol2012https://conductscience.org/library/papers/22782597PubMed
119847271Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.Am J Respir Crit Care Med1998https://conductscience.org/library/papers/9847271PubMed
1229792287Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial.Lancet Respir Med2018https://conductscience.org/library/papers/29792287PubMed
1327876247Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis.Lancet Respir Med2017https://conductscience.org/library/papers/27876247PubMed
1425927225Comparing new treatments for idiopathic pulmonary fibrosis--a network meta-analysis.BMC Pulm Med2015https://conductscience.org/library/papers/25927225PubMed
1522257422Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis.Respirology2012https://conductscience.org/library/papers/22257422PubMed
1628257580A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly.Am J Respir Cell Mol Biol2017https://conductscience.org/library/papers/28257580PubMed
1716306520High-dose acetylcysteine in idiopathic pulmonary fibrosis.N Engl J Med2005https://conductscience.org/library/papers/16306520PubMed
1826843176Treatment of idiopathic pulmonary fibrosis: a network meta-analysis.BMC Med2016https://conductscience.org/library/papers/26843176PubMed
1926308723Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.PLoS One2015https://conductscience.org/library/papers/26308723PubMed
2031365829Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE).Am J Respir Crit Care Med2019https://conductscience.org/library/papers/31365829PubMed

See all 92 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
41297960Clinical care in interstitial lung disease: a critical appraisal of clinical guidance documents.Eur Respir Rev2025https://conductscience.org/library/papers/41297960PubMed
38965496Association between swallowing dynamics, tongue pressure and pulmonary function in patients with idiopathic pulmonary fibrosis.BMC Pulm Med2024https://conductscience.org/library/papers/38965496PubMed
38791861Improving Accessibility to Patients with Interstitial Lung Disease (ILD): Barriers to Early Diagnosis and Timely Treatment in Latin America.Int J Environ Res Public Health2024https://conductscience.org/library/papers/38791861PubMed
37909628Psychometric assessment of oral health-related quality of life questionnaires cross-culturally adapted for use in Brazilian adults - a systematic review.Rev Bras Epidemiol2023https://conductscience.org/library/papers/37909628PubMed
34495179Pulmonary fibrosis and follow-up of COVID-19 survivors: an urgent need for clarification.J Bras Pneumol2021https://conductscience.org/library/papers/34495179PubMed
33503137Achievements of the last biennium, projections for the coming years, and the impact of COVID-19.J Bras Pneumol2021https://conductscience.org/library/papers/33503137PubMed
33313150Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis.Ann Transl Med2020https://conductscience.org/library/papers/33313150PubMed
32402013Pharmacological treatment of idiopathic pulmonary fibrosis: time to step out of the comfort zone?J Bras Pneumol2020https://conductscience.org/library/papers/32402013PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EDN11906PubTator's text mininghttps://conductscience.org/library/genes/1906NCBI Gene
PDE5A8654PubTator's text mininghttps://conductscience.org/library/genes/8654NCBI Gene
SFTPD6441PubTator's text mininghttps://conductscience.org/library/genes/6441NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene
TOLLIP54472PubTator's text mininghttps://conductscience.org/library/genes/54472NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32130337

GET https://conductscience.org/api/papers/v1/32130337/authors?page=2